OrganiGram Holdings Inc
TSX:OGI
OrganiGram Holdings Inc
TSX:OGI
Price:
1.87
CAD
-1.06%
Market Cap:
CA$252.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
OrganiGram Holdings Inc
TSX:OGI
|
CA |
|
B
|
Brilliant AG
XBER:BAG
|
DE |
|
M
|
M Pictures Entertainment PCL
SET:MPIC
|
TH |
|
A
|
Affin Bank Bhd
KLSE:AFFIN
|
MY |
|
J
|
Jiangsu Changqing Agrochemical Co Ltd
SZSE:002391
|
CN |
|
I
|
Indexa Capital Group SA
MAD:INDXA
|
ES |
|
P
|
Petrovietnam Gas Joint Stock Corp
VN:GAS
|
VN |
|
Z
|
Zynga Inc
LSE:0R0J
|
US |
|
Blackbird PLC
LSE:BIRD
|
UK |
|
S
|
Sanai Health Industry Group Co Ltd
HKEX:1889
|
HK |
|
Mianyang Fulin Precision Co Ltd
SZSE:300432
|
CN |
|
I
|
Italian Sea Group SpA
MIL:TISG
|
IT |
|
Alkem Laboratories Ltd
BSE:539523
|
IN |
|
Expedia Group Inc
NASDAQ:EXPE
|
US |
|
F
|
Fortune Ng Fung Food Hebei Co Ltd
SSE:600965
|
CN |
|
BRB-Banco de Brasilia SA
BOVESPA:BSLI4
|
BR |
|
Godolphin Resources Ltd
ASX:GRL
|
AU |
|
IRB Brasil Resseguros SA
BOVESPA:IRBR3
|
BR |
|
G50 Corp Ltd
OTC:GFTYF
|
AU |
|
H
|
Hatcher Group Ltd
HKEX:8365
|
HK |
|
C
|
Coloray International Investment Co Ltd
KOSDAQ:900310
|
HK |
Relative Value
The Relative Value of one
OGI
stock under the Base Case scenario is
hidden
CAD.
Compared to the current market price of 1.87 CAD,
OrganiGram Holdings Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
OGI Relative Value
HIDDEN
Multiples Across Competitors
OGI Competitors Multiples
OrganiGram Holdings Inc Competitors
OrganiGram Holdings Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
OrganiGram Holdings Inc
TSX:OGI
|
252.7m CAD | 0.9 | 13.9 | -4.4 | -3.5 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
860.3B USD | 13.1 | 41.3 | 27.9 | 29.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.9B USD | 6 | 21.1 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 3.9 | 18.8 | 11.2 | 12.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
213.1B GBP | 4.9 | 28 | 15.6 | 22 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
286.3B USD | 4.4 | 15.8 | 9.8 | 11.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
222.8B CHF | 5.1 | 20.7 | 12.8 | 16.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.3 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
152.2B USD | 2.5 | 19.7 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
114.7B USD | 2.4 | 16.4 | 7 | 8.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
